These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15808469)

  • 21. Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II.
    Hasinoff BB; Wu X; Begleiter A; Guziec LJ; Guziec F; Giorgianni A; Yang S; Jiang Y; Yalowich JC
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):221-33. PubMed ID: 16010589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba.
    Suzuki K; Yahara S; Maehata K; Uyeda M
    J Nat Prod; 2001 Feb; 64(2):204-7. PubMed ID: 11430001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity.
    Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY
    Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
    Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
    Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of DNA topoisomerases II and/or I by pyrazolo[1,5-a]indole derivatives and their growth inhibitory activities.
    Umemura K; Mizushima T; Katayama H; Kiryu Y; Yamori T; Andoh T
    Mol Pharmacol; 2002 Oct; 62(4):873-80. PubMed ID: 12237334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.
    Nacro K; Zha CC; Guzzo PR; Jason Herr R; Peace D; Friedrich TD
    Bioorg Med Chem; 2007 Jun; 15(12):4237-46. PubMed ID: 17418582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two new benzofurans from Gastrodia elata and their DNA topoisomerases I and II inhibitory activities.
    Lee YK; Woo MH; Kim CH; Kim Y; Lee SH; Jeong BS; Chang HW; Son JK
    Planta Med; 2007 Oct; 73(12):1287-91. PubMed ID: 17973203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro.
    Constantinou A; Stoner GD; Mehta R; Rao K; Runyan C; Moon R
    Nutr Cancer; 1995; 23(2):121-30. PubMed ID: 7644381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA binding properties of 9-substituted harmine derivatives.
    Cao R; Peng W; Chen H; Ma Y; Liu X; Hou X; Guan H; Xu A
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1557-63. PubMed ID: 16288723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of DNA topoisomerase I and II, and growth inhibition of MDA-MB-231 human breast cancer cells by bis-benzimidazole derivatives with alkylating moiety.
    Bielawski K; Wołczyński S; Bielawska A
    Pol J Pharmacol; 2004; 56(3):373-8. PubMed ID: 15215569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on cytotoxic, hydroxyl radical scavenging and topoisomerase inhibitory activities of extracts of Tabernaemontana divaricata (L.) R.Br. ex Roem. and Schult.
    Thind TS; Agrawal SK; Saxena AK; Arora S
    Food Chem Toxicol; 2008 Aug; 46(8):2922-7. PubMed ID: 18577413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity.
    Langer SW; Schmidt G; Sørensen M; Sehested M; Jensen PB
    Clin Cancer Res; 1999 Oct; 5(10):2899-907. PubMed ID: 10537359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II.
    Kawiak A; Piosik J; Stasilojc G; Gwizdek-Wisniewska A; Marczak L; Stobiecki M; Bigda J; Lojkowska E
    Toxicol Appl Pharmacol; 2007 Sep; 223(3):267-76. PubMed ID: 17618663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
    Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
    Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer.
    Wang SJ; Peyrollier K; Bourguignon LY
    Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):281-8. PubMed ID: 17372087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, topoisomerase I inhibition and structure-activity relationship study of 2,4,6-trisubstituted pyridine derivatives.
    Zhao LX; Moon YS; Basnet A; Kim EK; Jahng Y; Park JG; Jeong TC; Cho WJ; Choi SU; Lee CO; Lee SY; Lee CS; Lee ES
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1333-7. PubMed ID: 14980693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural analysis of isosteviol and related compounds as DNA polymerase and DNA topoisomerase inhibitors.
    Mizushina Y; Akihisa T; Ukiya M; Hamasaki Y; Murakami-Nakai C; Kuriyama I; Takeuchi T; Sugawara F; Yoshida H
    Life Sci; 2005 Sep; 77(17):2127-40. PubMed ID: 15935396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA topoisomerase I inhibitory alkaloids from Corydalis saxicola.
    Cheng X; Wang D; Jiang L; Yang D
    Chem Biodivers; 2008 Jul; 5(7):1335-44. PubMed ID: 18649321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.
    Kim JS; Rhee HK; Park HJ; Lee IK; Lee SK; Suh ME; Lee HJ; Ryu CK; Choo HY
    Bioorg Med Chem; 2007 Jan; 15(1):451-7. PubMed ID: 17035025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives.
    Cheng Y; An LK; Wu N; Wang XD; Bu XZ; Huang ZS; Gu LQ
    Bioorg Med Chem; 2008 Apr; 16(8):4617-25. PubMed ID: 18296054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.